MNKD Q1 2019 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+403.5% YoY

Gross Profit

$12M68.2% margin

Operating Income

-$14M-77.5% margin

Net Income

-$15M-85.3% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+8.8%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$999,000

Balance Sheet

Total Assets

$101M

Total Liabilities

$289M

Stockholders' Equity

-$188M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$3M	+403.5%
Gross Profit	$12M	-$543,000	+2289.9%
Operating Income	-$14M	-$27M	+49.6%
Net Income	-$15M	-$30M	+51.0%

Revenue Segments

Product

$5M100%